(Q35788769)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22448335%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Internal Quality Assurance Program for ERBB2 (HER2) Testing Improves the Selection of Breast Cancer Patients for Treatment with Trastuzumab (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22448335%20AND%20SRC:MED&resulttype=core&format=json

Erb-b2 receptor tyrosine kinase 2

26 January 2020

main subject

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22448335%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Vittoria Martin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22448335%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Antonella Camponovo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22448335%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Morena Ghisletta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22448335%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Luca Mazzucchelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22448335%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

14 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22448335%20AND%20SRC:MED&resulttype=core&format=json

Pathology Research International

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22448335%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22448335%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

261857

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22448335%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 3.0 Unported

26 January 2020

copyright license

start time

14 February 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289840

External quality assurance of HER2 FISH and ISH testing: three years of the UK national external quality assurance scheme

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289840

Trastuzumab for early breast cancer: current status and future directions.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289840

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289840

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289840

Standardization of HER2 testing: results of an international proficiency-testing ring study.

12 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261857

Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261857

Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261857

Human epidermal growth factor receptor 2 expression in early breast cancer patients: a Swiss cost-effectiveness analysis of different predictive assay strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F261857

21 January 2018

Identifiers

DOI

10.1155/2012/261857

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22448335%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22448335%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

PubMed publication ID

22448335

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22448335%20AND%20SRC:MED&resulttype=core&format=json